Chemical Biology

Date: Tuesday, 19 March 2013 - Wednesday, 20 March 2013
Location: Munich, Germany

Keynote Speakers

Hiroaki Suga
Professor, The University of Tokyo

Mark Bradley
Professor of Therapeutic Innovation, Precision Healthcare University Research Institute, Queen Mary University of London

Barry Potter
Professor, University of Bath

Overview

Chemical biology is a sub-discipline of pharmacology which encompasses a wide range of fundamental topics. This conference will investigate a snapshot of this field, concentrating on the cutting-edge concepts and tools which will aid with drug discovery. Our speakers have collaborated to select material that will help delegates with the design and chemical modification of substrates; this will include integral information, such as new methods for introducing conformational changes, novel analytical techniques to increase the selectivity and specificity of elaborate biological systems.

Session Sponsors

Agenda Topics

Chemical Cell Biology and Cancer
Chemical Proteomics
Drug Design Strategies: Click Chemistry
Polypharmacology and Drug Repurposing

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Jurgen Bajorath, Professor, Rheinische Friedrich Wilhelms University of Bonn
Marc Blondel, Professor, University of Brest
Stephen Caddick, Vice Provost for Enterprise, University College London
Richard Doveston, Researcher, Leeds University
Jutta Eichler, Professor, University of Erlangen-Nuremberg
Mikael Elofsson, Professor/Associate Head, Umea University
Stefan Krauss, NCS Director, University of Oslo
Guillaume Medard, Group Leader, Technical University of Munich
Morten Meldal, Professor Head of Nano-Science Center, University of Copenhagen
Huib Ovaa, Group Leader, Netherlands Cancer Institute
Stephen Pennington, Professor, University College Dublin
Uwe Rix, Assistant Member/Professor, Moffitt Cancer Center
Edward Tate, Professor of Chemical Biology, Imperial College London
Krister Wennerberg, Group Leader, Institute for Molecular Medicine Finland